Skyrocketing demand coupled with shortages of vital components is leading to bottlenecks in the supply chain of Pfizer’s and other mRNA vaccines.
Academic rigour, journalistic flair
Articles on Supply chains
Displaying 141 - 160 of 257 articles
Supply chain finance is now in jeopardy.
Modern supply chains have become very efficient, but that means disruptions of any kind can lead to delays and shortages.
Right now, the nation is almost entirely dependent on other countries for minerals that are used in everything from wind turbines to strike fighters and satellites.
Before the container was standardized, loading and unloading goods was very labor-intensive, inefficient and costly.
Direct implications for maritime security are unlikely. But there will be ripple effects in the shipping industry and in many commercial sectors.
A bottleneck in the global shipping network will accelerate the move to more local production and shorter supply chains.
Exports of the vaccine continue to be a point of contention between the EU and UK, while newly released US trial results are quickly amended.
Pressure from business leaders and a simple legislative process leave few excuses for not introducing rules to combat modern slavery in commercial supply chains.
The high cost and long lead times for building computer chip factories makes it difficult for the U.S. to reverse the steady decline of its domestic semiconductor manufacturing capacity.
Hospitals have a lot of room to reduce, reuse and recycle supplies – as many were forced to discover during the pandemic.
The hard work of eliminating plastic waste must start with businesses.
Another local lockdown, another outbreak of shoppers stockpiling. Fortunately supply chains are now prepared.
West Virginia’s success holds some important lessons for other states and the rest of the COVID-19 vaccine rollout.
With reports emerging of vaccine wastage across the world, medical supply chain experts explain why that’s to be expected.
Whether it’s health-care workers, kids in school or people running errands, Canadians need face masks during COVID-19. There’s no reason they shouldn’t be made here at home.
The vaccines’ cold storage requirements and shipment rules put small, rural communities at a disadvantage, but that’s only part of a long-running challenge.
A pharmaceutical supply chain expert explains the challenges of distributing the COVID-19 vaccines from Pfizer and Moderna that need to be kept at very low temperatures.
Logistics is the unsung hero in vaccination. But here’s why it’s critical.
We’re on the road again. Getting enough COVID-19 vaccine to where it’s needed in a given time frame is the next logistical hurdle.
Top contributors
-
Associate Dean - School of Business and Law, Edith Cowan University
-
Professor and Eugene M. Isenberg Chair in Integrative Studies, UMass Amherst
-
Deputy Director of the HUMLOG (Humanitarian Logistics and Supply Chain Management Research) Institute, Hanken School of Economics
-
Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Professor of Health Service Operations, University of Bradford
-
Associate Professor of Operations & Project Management, Manchester Metropolitan University
-
Professor in Sustainable Production and Consumption, Anglia Ruskin University
-
Senior Lecturer in Operations and Supply Chain Management, Anglia Ruskin University
-
Lecturer in Logistics, Technological University Dublin
-
Distinguished Professor of Supply Chain Management, Northeastern University
-
Professor of Logistics and Supply Chain Management, Heriot-Watt University
-
Professor of Operations and Supply Chain Management, City, University of London
-
Associate Professor, University of Sydney
-
Associate Professor of Supply Chain & Analytics, University of Missouri-St. Louis
-
Bernard T. Ferrari Professor of Business, Johns Hopkins University
-
Professor of Accounting, University of Portsmouth
